Viewing StudyNCT00261313



Ignite Creation Date: 2024-05-05 @ 4:34 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00261313
Status: COMPLETED
Last Update Posted: 2010-02-26
First Post: 2005-12-02

Brief Title: ACCELERATE Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Adjuvant Breast Cancer View
Breast cancer View
Doses dense chemotherapy View
Growth factor support View